N

NanoViricides
D

NNVC

1.31500
USD
0.04
(2.73%)
Market Open
Volume
300
EPS
0
Div Yield
-
P/E
-2
Market Cap
18,866,305
OverviewSignalsIdeasNews
Related Instruments
    A
    ALT
    -0.85500
    (-10.11%)
    7.60000 USD
    A
    AVIR
    -0.09000
    (-2.72%)
    3.22000 USD
    B
    BNTX
    -3.740
    (-3.61%)
    99.740 USD
    I
    INO
    -0.54000
    (-11.25%)
    4.26000 USD
    MRNA
    MRNA
    -2.950
    (-7.42%)
    36.830 USD
    N
    NVAX
    0.12000
    (1.67%)
    7.32500 USD
    V
    VIR
    -0.63500
    (-7.35%)
    8.01000 USD
    V
    VXRT
    -0.05030
    (-7.97%)
    0.58050 USD
    More
News

Title: NanoViricides

Sector: Healthcare
Industry: Biotechnology
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in theapplication of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.